Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Endo International News

    0,0006 $ 0,00% +0,00 $
    In : 0,0006 € | 01.05.24 20:16:01 Nasdaq OTC Other aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A1XE6M
    ISIN: IE00BJ3V9050
    US-Symbol: ENDPQ
    Typ: Aktie

    Endo International News

    22.04.24 - PR Newswire
    Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
    Par Pharmaceutical Issues Voluntary Nationwide Recall of Seven Lots of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution PR Newswire
    26.03.24 - PR Newswire
    Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
    Endo Launches Ibuprofen-​Famotidine Tablets, Generic Version of DUEXIS® PR Newswire
    26.03.24 - PR Newswire
    Endo Launches Ibuprofen-Famotidine Tablets, Generic Version of DUEXIS®
    Endo Launches Ibuprofen-​Famotidine Tablets, Generic Version of DUEXIS® PR Newswire
    19.03.24 - PR Newswire
    Endo Announces Confirmation of Plan of Reorganization
    Endo Announces Confirmation of Plan of Reorganization PR Newswire
    19.03.24 - PR Newswire
    Endo Announces Confirmation of Plan of Reorganization
    Endo Announces Confirmation of Plan of Reorganization PR Newswire
    12.03.24 - PR Newswire
    Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution
    Par Pharmaceutical Issues Voluntary Nationwide Recall of One Lot of Treprostinil Injection Due to Potential for Silicone Particulates in the Product Solution PR Newswire
    06.03.24 - PR Newswire
    ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
    ENDO REPORTS FOURTH-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
    06.03.24 - PR Newswire
    ENDO REPORTS FOURTH-QUARTER 2023 FINANCIAL RESULTS
    ENDO REPORTS FOURTH-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
    29.02.24 - PR Newswire
    Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
    Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER PR Newswire
    29.02.24 - PR Newswire
    Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER
    Endo Reaches Resolution with U.S. Department of Justice Regarding Legacy Marketing of Opana® ER PR Newswire
    24.01.24 - PR Newswire
    Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
    Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open PR Newswire
    24.01.24 - PR Newswire
    Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open
    Endo Announces Publication of New XIAFLEX® (collagenase clostridium histolyticum) Survey Data in Journal of Hand Surgery Global Open PR Newswire
    30.11.23 - PR Newswire
    Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
    Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients PR Newswire
    30.11.23 - PR Newswire
    Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients
    Endo Launches Unscripted Video Series With Real Peyronie's Disease Patients PR Newswire
    16.11.23 - PR Newswire
    Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
    Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire
    16.11.23 - PR Newswire
    Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting
    Endo Announces Five Presentations at the Sexual Medicine Society of North America (SMSNA) Annual Meeting PR Newswire
    06.11.23 - PR Newswire
    ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
    ENDO REPORTS THIRD-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
    06.11.23 - PR Newswire
    ENDO REPORTS THIRD-QUARTER 2023 FINANCIAL RESULTS
    ENDO REPORTS THIRD-​QUARTER 2023 FINANCIAL RESULTS PR Newswire
    21.09.23 - PR Newswire
    Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
    Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire
    21.09.23 - PR Newswire
    Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting
    Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting PR Newswire

    Newssuche

    Videos

    newspaper
    30.04.24 -9,41%
    Technical Trading: Sojabohnen Long bis Juli
    Sojabohnen Long Typ: Turbo Open End WKN: VX41AH Hebel: 5 Laufzeit: OpenEnd Einstieg: Market ... Mehr »